In 1992, Giller et al. isolated mRNA coding for two novel human pancreatic lipase-related proteins (PLRPs) showing a high level of identity with the human classic pancreatic lipase [1]. On the basis of amino acid sequence comparisons, Giller et al. proposed the classification of pancreatic lipases in three subgroups: classic pancreatic lipase (PL), PLRP1 and PLRP2. Numerous PLRP sequences have been identified in several species by isolating mRNA [2][3][4][5][6][7][8][9][10][11]. Furthermore, by using classic protein purification procedures, the presence of PLRP1 and ⁄ or PLRP2 has been demonstrated in the pancreas or in the pancreatic juice from different species and also in other secretions [8,[11][12][13][14][15].PLRP and PL differ in enzymatic properties such as substrate specificity, sensitivity to inhibition by bile salts and colipase dependence [16]. Pancreatic lipases are highly active and selective for triglyceride substrates. Under physiological conditions, the PL activity is dependent on the presence of colipase, which able to overcome the inhibitory effect of bile salts [17,18]. Despite extensive studies on a large variety of substrates, only very low lipolytic activity against triglycerides has been reported with PLRP1 [1,4,14,15] Although structurally similar, classic pancreatic lipase (PL) and pancreatic lipase-related protein (PLRP)2, expressed in the pancreas of several species, differ in substrate specificity, sensitivity to bile salts and colipase dependence. In order to investigate the role of the two domains of PLRP2 in the function of the protein, two chimeric proteins were designed by swapping the N and C structural domains between the horse PL (Nc and Cc domains) and the horse PLRP2 (N2 and C2 domains). NcC2 and N2Cc proteins were expressed in insect cells, purified by one-step chromatography, and characterized. NcC2 displays the same specific activity as PL, whereas N2Cc has the same as that PLRP2. In contrast to N2Cc, NcC2 is highly sensitive to interfacial denaturation. The lipolytic activity of both chimeric proteins is inhibited by bile salts and is not restored by colipase. Only N2Cc is found to be a strong inhibitor of PL activity, due to competition for colipase binding. Active site-directed inhibition experiments demonstrate that activation of N2Cc occurs in the presence of bile salt and does not require colipase, as does PLRP2. The inability of PLRP2 to form a high-affinity complex with colipase is only due to the C-terminal domain. Indeed, the N-terminal domain can interact with the colipase. PLRP2 properties such as substrate selectivity, specific activity, bile salt-dependent activation and interfacial stability depend on the nature of the N-terminal domain.